Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Effects of atorvastatin on the clearance of triglyceride-rich lipoproteins in familial combined hyperlipidemia.

Castro Cabezas M, Verseyden C, Meijssen S, Jansen H, Erkelens DW.

J Clin Endocrinol Metab. 2004 Dec;89(12):5972-80.

PMID:
15579746
2.
3.

Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia.

Boquist S, Karpe F, Danell-Toverud K, Hamsten A.

Atherosclerosis. 2002 May;162(1):163-70.

PMID:
11947910
4.

MTP gene polymorphisms and postprandial lipemia in familial combined hyperlipidemia: effects of treatment with atorvastatin.

Klop B, Verseyden C, Ribalta J, Salazar J, Masana L, Cabezas MC.

Clin Investig Arterioscler. 2014 Mar-Apr;26(2):49-57. doi: 10.1016/j.arteri.2013.11.006.

PMID:
24378322
5.

Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia.

Verseyden C, Meijssen S, Castro Cabezas M.

J Lipid Res. 2002 Feb;43(2):274-80.

6.

Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia.

Verseyden C, Meijssen S, van Dijk H, Jansen H, Castro Cabezas M.

J Lipid Res. 2003 Nov;44(11):2100-8.

7.

Atorvastatin reduces postprandial accumulation and cholesteryl ester transfer protein-mediated remodeling of triglyceride-rich lipoprotein subspecies in type IIb hyperlipidemia.

Guerin M, Egger P, Le Goff W, Soudant C, Dupuis R, Chapman MJ.

J Clin Endocrinol Metab. 2002 Nov;87(11):4991-5000.

PMID:
12414863
8.

Experimental model of postprandial hypertriglyceridemia in sucrose-fed rats and the effectiveness of atorvastatin in the model.

Funatsu T, Kakuta H, Takasu T, Noguchi M, Suzuki M, Miyata K.

Metabolism. 2003 May;52(5):609-15.

PMID:
12759892
9.

Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients.

Parhofer KG, Laubach E, Barrett PH.

J Lipid Res. 2003 Jun;44(6):1192-8.

10.
11.

Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy.

Arca M, Natoli S, Micheletta F, Riggi S, Di Angelantonio E, Montali A, Antonini TM, Antonini R, Diczfalusy U, Iuliano L.

Free Radic Biol Med. 2007 Mar 1;42(5):698-705.

PMID:
17291993
13.

The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.

Burnett JR, Barrett PH, Vicini P, Miller DB, Telford DE, Kleinstiver SJ, Huff MW.

Arterioscler Thromb Vasc Biol. 1998 Dec;18(12):1906-14.

14.

Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.

Le NA, Innis-Whitehouse W, Li X, Bakker-Arkema R, Black D, Brown WV.

Metabolism. 2000 Feb;49(2):167-77.

PMID:
10690940
15.

Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients.

Ikejiri A, Hirano T, Murayama S, Yoshino G, Gushiken N, Hyodo T, Taira T, Adachi M.

Metabolism. 2004 Sep;53(9):1113-7.

PMID:
15334369
16.

Atorvastatin versus four statin-fibrate combinations in patients with familial combined hyperlipidaemia.

Athyros VG, Papageorgiou AA, Athyrou VV, Demitriadis DS, Pehlivanidis AN, Kontopoulos AG.

J Cardiovasc Risk. 2002 Feb;9(1):33-9.

PMID:
11984215
17.

Comparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemia.

Melenovsky V, Malik J, Wichterle D, Simek J, Pisarikova A, Skrha J, Poledne R, Stavek P, Ceska R.

Am Heart J. 2002 Oct;144(4):E6.

PMID:
12360175
18.

Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins.

Ishigami M, Yamashita S, Sakai N, Hirano K, Hiraoka H, Nakamura T, Matsuzawa Y.

Atherosclerosis. 2003 Jun;168(2):359-66.

PMID:
12801620
19.

Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin.

Sirtori CR, Calabresi L, Pisciotta L, Cattin L, Pauciullo P, Montagnani M, Manzato E, Bittolo Bon G, Fellin R.

Nutr Metab Cardiovasc Dis. 2005 Feb;15(1):47-55.

PMID:
15871851

Supplemental Content

Support Center